IS3B:XETRA:XETRA-iShares € Corp Bond Financials UCITS ETF EUR (Dist) (EUR)

ETF | Others |

Last Closing

USD 101.985

Change

-0.20 (-0.20)%

Market Cap

USD 0.33B

Volume

1.06K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-25 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.14 (-0.28%)

USD 484.40B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.04 (-0.23%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.06 (-0.21%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.07 (-0.23%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.05 (+0.21%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.03 (-0.05%)

USD 100.74B
8R80:XETRA Amundi Index Solutions - Amund..

+0.50 (+0.35%)

USD 98.29B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.09 (-0.18%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+0.54 (+0.10%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.04 (-0.17%)

USD 79.79B

ETFs Containing IS3B:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.54% 31% F 36% F
Dividend Return 1.44% 50% F 33% F
Total Return 3.98% 38% F 42% F
Trailing 12 Months  
Capital Gain 6.82% 30% F 36% F
Dividend Return 2.95% 76% C+ 58% F
Total Return 9.77% 39% F 43% F
Trailing 5 Years  
Capital Gain -8.19% 20% F 27% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.19% 18% F 23% F
Average Annual (5 Year Horizon)  
Capital Gain -2.23% 19% F 21% F
Dividend Return -1.49% 20% F 22% F
Total Return 0.74% 55% F 36% F
Risk Return Profile  
Volatility (Standard Deviation) 6.62% 75% C 80% B-
Risk Adjusted Return -22.46% 21% F 21% F
Market Capitalization 0.33B 56% F 50% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.